Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans

被引:36
作者
Caraher, Emma
Duff, Caroline
Mullen, Tracy
Mc Keon, Suzanne
Murphy, Philip
Callaghan, Maire
McClean, Siobhan [1 ]
机构
[1] Natl Inst Cellular Biotechnol, Inst Technol, Dept Appl Sci, Dublin 24, Ireland
[2] Adelaide Meath & Natl Childrens Hosp Tallaght, Dublin 24, Ireland
[3] Univ Dublin Trinity Coll, Dept Clin Med, Dublin 2, Ireland
关键词
Burkholderia cepacia complex; Burkholderia dolosa; virulence; biofilm; invasion;
D O I
10.1016/j.jcf.2006.05.007
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Colonisation with Burkholderia cepacia complex pathogens has been associated with accelerated decline in cystic fibrosis (CF) patients. The two most common species among the CF community are Burkholderia cenocepacia and Burkholderia multivorans. However, Burkholderia dolosa has recently been causing concern due to its transmissibility and virulence in CF patients. Methods: We have compared the ability of five B. dolosa strains to invade lung epithelial cells in vitro with other members of the Bcc. The bacterial epithelial cell interaction was visualised by transmission electron microscopy. We have also examined the ability of these strains to form biofilms in vitro. Results: We have found that members of this species can invade pulmonary epithelial cells in vitro as readily as those from B. cenocepacia and B. multivorans. Confirmation of intracellular invasion was obtained by transmission electron microscopy. B. dolosa strains were readily observed in membrane bound vesicles inside the lung epithelial cells. In addition, strains from this species were capable of fori-ning strong biofilms at a level comparable to the more clinically relevant species. Conclusions: B. dolosa shows comparable virulence characteristics in vitro to the two most clinically relevant species indicating precautions should be taken when this species is identified in the CF population. (C) 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 21 条
[1]   Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis [J].
Biddick, R ;
Spilker, T ;
Martin, A ;
LiPuma, JJ .
FEMS MICROBIOLOGY LETTERS, 2003, 228 (01) :57-62
[2]  
CARAHER E, UNPUB J ANTIMICROB C
[3]   Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection [J].
Cieri, MV ;
Mayer-Hamblett, N ;
Griffith, A ;
Burns, JL .
INFECTION AND IMMUNITY, 2002, 70 (03) :1081-1086
[4]   Updated version of the Burkholderia cepacia complex experimental strain panel [J].
Coenye, T ;
Vandamme, P ;
LiPuma, JJ ;
Govan, JRW ;
Mahenthiralingam, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (06) :2797-2798
[5]   Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex [J].
Conway, BAD ;
Venu, V ;
Speert, DP .
JOURNAL OF BACTERIOLOGY, 2002, 184 (20) :5678-5685
[6]   Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections [J].
Cunha, MV ;
Sousa, SA ;
Leitao, JH ;
Moreira, LM ;
Videira, PA ;
Sá-Correia, I .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (07) :3052-3058
[7]  
DESAI M, 1990, J ANTIMICROB CHEMOTH, V42, P152
[8]   In vitro antibacterial properties of pexiganan, an analog of magainin [J].
Ge, YG ;
MacDonald, DL ;
Holroyd, KJ ;
Thornsberry, C ;
Wexler, H ;
Zasloff, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :782-788
[9]   Pathophysiology and management of pulmonary infections in cystic fibrosis [J].
Gibson, RL ;
Burns, JL ;
Ramsey, BW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (08) :918-951
[10]   Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis [J].
Kalish, LA ;
Waltz, DA ;
Dovey, M ;
Potter-Bynoe, G ;
McAdam, AJ ;
LiPuma, JJ ;
Gerard, C ;
Goldmann, D .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (04) :421-425